CAR T-cells for the treatment of CNS malignancies
Chimeric antigen receptor (CAR) T-cell therapy has undergone great advances since the development of the first-generation CAR in the early 1990s. Currently there are seven FDA approved CAR T-cell therapies for the treatment of hematological malignancie…